scispace - formally typeset
Journal ArticleDOI

Predictors of Side Branch Compromise in Calcified Bifurcation Lesions Treated With Orbital Atherectomy

TLDR
The aim of the study was to identify the predictors of side branch (SB) compromise in severely calcified bifurcation lesions treated with orbital atherectomy (OA).
Abstract
OBJECTIVES The aim of the study was to identify the predictors of side branch (SB) compromise in severely calcified bifurcation lesions treated with orbital atherectomy (OA). BACKGROUND SB compromise remains a major complication of bifurcation lesion percutaneous coronary intervention (PCI). Higher prevalence of lipid-rich plaques and spotty calcification by optical coherence tomography (OCT) and SB ostial stenosis by angiography have been previously suggested as predictors of SB occlusion after main vessel (MV) stenting. METHODS Patients with chronic stable angina and severely calcified bifurcation lesions, in whom provisional stenting strategy was planned, were enrolled in the study. OA was used for lesion preparation in all cases. OCT imaging of the MV was performed before and after stenting. SB compromise was defined as a composite of SB occlusion (TIMI flow grade ≤ 2) and SB intervention after MV stenting. RESULTS Thirty stable CAD patients with 30 severely calcified bifurcation lesions were included in the study. Twelve patients (40%) had a compromised SB after MV stenting. Compromised SB was characterized by a greater angiographic diameter stenosis (55.4 ± 8.1% vs. 35.0 ± 14.4%, P < 0.01) and a smaller minimal lumen diameters (0.79 ± 0.17 vs. 1.12 ± 0.30 mm, P = 0.002) before PCI compared to noncompromised SB. The prevalence of OCT lipid-rich plaques was low and did not differ between the groups (18 vs. 19%, P = 0.68). There was no difference in other OCT plaque characteristics including the presence of spotty calcification. CONCLUSION The severity of SB ostial disease and not MV plaque morphology contributed to SB compromise in severely calcified bifurcation lesions.

read more

Citations
More filters
Journal ArticleDOI

Maximum calcium thickness is a useful predictor for acceptable stent expansion in moderate calcified lesions.

TL;DR: Maximum calcium thickness < 880 µm is a useful predictor for acceptable stent expansion in moderate calcified lesions in patients who underwent optical coherence tomography guided percutaneous coronary intervention (PCI) between January 2017 and March 2019.
Journal ArticleDOI

Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.

TL;DR: This work evaluated the procedural and 1‐year clinical outcomes of orbital atherectomy for treatment of coronary in‐stent restenosis (ISR) and concluded that OA should be considered as a standalone treatment for ISR.
Journal ArticleDOI

Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single‐center registry study

TL;DR: The presence of a bifurcating target vessel with moderate/severe calcification is associated with a higher risk of adverse outcomes than either attribute alone, and new approaches are needed to improve outcomes in this subset of patients with complex coronary artery disease.
Journal ArticleDOI

Management of calcified coronary artery bifurcation lesions

TL;DR: A simplified approach to treating CBL is presented and the approach to specific case examples using the newly developed mobile application, BifurcAID is demonstrated.
References
More filters
Journal ArticleDOI

Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.

TL;DR: This document may be broadly used as a standard reference regarding the current state of theIVOCT imaging modality, intended for researchers and clinicians who use IVOCT and analyze IVO CT data.
Journal ArticleDOI

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

TL;DR: The hypothesis that increases in HDLc and decreases in TC (or LDLc) can prevent or delay CAD progression is supported, and the effect of cholestyramine treatment on CAD progression was eliminated with multivariate analysis.
Related Papers (5)